BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36178264)

  • 21. Pharmacological blockage of ICAM-1 improves angiotensin II-induced cardiac remodeling by inhibiting adhesion of LFA-1
    Lin QY; Lang PP; Zhang YL; Yang XL; Xia YL; Bai J; Li HH
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1301-H1311. PubMed ID: 31729904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiomyocyte-Specific
    Thirugnanam K; Cossette SM; Lu Q; Chowdhury SR; Harmann LM; Gupta A; Spearman AD; Sonin DL; Bordas M; Kumar SN; Pan AY; Simpson PM; Strande JL; Bishop E; Zou MH; Ramchandran R
    J Am Heart Assoc; 2019 Nov; 8(22):e012792. PubMed ID: 31718444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation.
    Ge W; Hou C; Zhang W; Guo X; Gao P; Song X; Gao R; Liu Y; Guo W; Li B; Zhao H; Wang J
    J Mol Cell Cardiol; 2021 Mar; 152():52-68. PubMed ID: 33301800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockage of AKAP12 accelerates angiotensin II (Ang II)-induced cardiac injury in mice by regulating the transforming growth factor β1 (TGF-β1) pathway.
    Li Y; Yu QH; Chu Y; Wu WM; Song JX; Zhu XB; Wang Q
    Biochem Biophys Res Commun; 2018 May; 499(2):128-135. PubMed ID: 29501491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.
    Meijles DN; Cull JJ; Markou T; Cooper STE; Haines ZHR; Fuller SJ; O'Gara P; Sheppard MN; Harding SE; Sugden PH; Clerk A
    Hypertension; 2020 Oct; 76(4):1208-1218. PubMed ID: 32903101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.
    McCollum LT; Gallagher PE; Ann Tallant E
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H801-10. PubMed ID: 22140049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling.
    Zhang C; Li Y; Wang C; Wu Y; Cui W; Miwa T; Sato S; Li H; Song WC; Du J
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1240-8. PubMed ID: 24743429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
    Sriramula S; Francis J
    PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
    Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
    Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
    J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-451a attenuates angiotensin II-induced cardiac fibrosis and inflammation by directly targeting T-box1.
    Deng HY; He ZY; Dong ZC; Zhang YL; Han X; Li HH
    J Physiol Biochem; 2022 Feb; 78(1):257-269. PubMed ID: 34851490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sclareol ameliorates hyperglycemia-induced renal injury through inhibiting the MAPK/NF-κB signaling pathway.
    Han X; Zhang J; Zhou L; Wei J; Tu Y; Shi Q; Zhang Y; Ren J; Wang Y; Ying H; Liang G
    Phytother Res; 2022 Jun; 36(6):2511-2523. PubMed ID: 35434887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation.
    Zouein FA; Zgheib C; Hamza S; Fuseler JW; Hall JE; Soljancic A; Lopez-Ruiz A; Kurdi M; Booz GW
    Hypertens Res; 2013 Jun; 36(6):496-503. PubMed ID: 23364341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
    Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
    Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
    Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
    Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II-Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal-Regulated Kinase/Nuclear Factor-κB Pathway.
    Zhu J; Li Q; Sun Y; Zhang S; Pan R; Xie Y; Chen J; Shi L; Chen Y; Sun Z; Zhang L
    J Am Heart Assoc; 2023 Sep; 12(18):e029631. PubMed ID: 37721135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation.
    Lin S; Dai S; Lin J; Liang X; Wang W; Huang W; Ye B; Hong X
    Cardiovasc Ther; 2022; 2022():3167959. PubMed ID: 35360548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II-Induced Hypertension.
    Callera GE; Antunes TT; He Y; Montezano AC; Yogi A; Savoia C; Touyz RM
    Hypertension; 2016 Nov; 68(5):1179-1190. PubMed ID: 27620391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.